| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |